Gentronix
- Katie Clare
KC
Katie Clare
Study Director at Gentronix
Katie joined the company in 2015 and is a cytogenetics and gene mutation Study Director. Prior to joining Gentronix, Katie worked in the Genetic Toxicology department of a leading pharmaceutical company for over 20 years, gaining extensive experience in performance and interpretation of GLP Genetic Toxicology studies.
Org chart
No direct reports
Timeline
Study Director
Current role